Status:
RECRUITING
Cancer Pain Management Using a Web-based Intervention
Lead Sponsor:
University of Texas at Austin
Conditions:
Cancer of Breast
Depressive Symptoms
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study is funded by the HEAL Initiative (https://heal.nih.gov/). Based on Preliminary Studies (PSs), the research team developed and pilot-tested an evidence-based Web App-based information and co...
Detailed Description
Due to advances in early detection and treatment, breast cancer survivors represent nearly 70% of the 5.6 million female cancer survivors in the U.S. These women usually have some combination of surge...
Eligibility Criteria
Inclusion
- women aged 18 years and older who identify as Chinese, Korean, or Japanese;
- have had a breast cancer diagnosis in the past;
- can read and write English, Mandarin (simplified or traditional), Korean, or Japanese;
- have access to the internet through computers or mobile devices (mobile phones and tablets);
- have experienced cancer pain during the past week (at least 1 on a scale from 0 to 5 \[no symptom=0, mild symptom that does not bother=1, somewhat bothering symptom=2, moderate symptom=3, severe symptom=4, and worst possible symptom=5\]);
- have experienced depressive symptoms during the past two weeks (1 to 10 on the Patient Health Questionnaire) which is equivalent to the cut-point of minimal to moderate depression.
Exclusion
- less than 18 years old because their cancer experience would be different from that of adults.
- Those who are in treatment or not in treatment, but who were diagnosed with breast cancer within the past five years, will be excluded.
- Those who participated in the PI's pilot studies will be excluded.
- The participants of R33 phase will exclude those in active depression treatment regardless of their level of depression.
- Those without Internet access will be excluded, but those with Internet access through community/group computers will be included.
Key Trial Info
Start Date :
February 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06085313
Start Date
February 20 2024
End Date
August 31 2027
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas at Austin
Austin, Texas, United States, 78712